Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Papillomavirus Infections

• Interferon Alpha Therapy for Cervical CINI and HPV Infection
• Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
• Treatment of HPV Infection in Perimenopausal and Postmenopausal Women
• Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
• "Lactobacillus Crispatus M247, LSIL and Microbiota"
• Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
• Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
• Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
• Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts
• A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years
• Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
• Lenvatinib and Pembrolizumab Combination Therapy In HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal, and/or Pulmonary Involvement
• Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female
• Study of the Impact of a School Program Combining - Promotion of HPV Vaccination and HPV Vaccine Offer in Middle School - on Adherence to HPV Vaccination in Middle School Students
• INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)
• Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection
• Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
• An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
• Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
• Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
• Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)
• A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects
• A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine
• M7824 in People With Recurrent Respiratory Papillomatosis
• Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
• Cantharidin and Occlusion in Verruca Epithelium
• Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial
• Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
• Avelumab for People With Recurrent Respiratory Papillomatosis
• E7 TCR T Cells for Human Papillomavirus-Associated Cancers
• Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
• BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer
• Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement
• Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
• Yallaferon in Chinese Population
• Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis
• Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)
• Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
• Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin
• On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
• Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix
• Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia
• A New Supplement for the Immune Response to HPV Infection
• Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
• Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
• Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
• Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
• Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
• Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections
• AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix Infections
• Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
• A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
• Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis
• Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)
• Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
• Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
• Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
• Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia
• Use of Cidofovir for Recurrent Respiratory Papillomatosis
• Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
• A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
• Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.